A robust covariate-balancing method for learning optimal individualized treatment regimes
学习最优个体化治疗规则的稳健协变量平衡方法AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要以个体化治疗决策、倾向得分和治疗价值估计为核心,直接对应因果推断。
学习最优个体化治疗规则的稳健协变量平衡方法AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
Abstract One of the most important problems in precision medicine is to find the optimal individualized treatment rule, which is designed to recommend treatment decisions and maximize overall clinical benefit to patients based on their individual characteristics. Typically, the expected clinical outcome is required to be estimated first, for which an outcome regression model or a propensity score model usually needs to be assumed with most existing statistical methods. However, if either model assumption is invalid, the estimated treatment regime will not be reliable. In this article, we first define a contrast value function, which forms the basis for the study of individualized treatment regimes. Then we construct a hybrid estimator of the contrast value function by combining two types of estimation methods. We further propose a robust covariate-balancing estimator of the contrast value function by combining the inverse probability weighted method and matching method, which is based on the covariate balancing propensity score proposed by Imai & Ratkovic (2014). Theoretical results show that the proposed estimator is doubly robust, ie, it is consistent if either the propensity score model or the matching is correct. Based on a large number of simulation studies, we demonstrate that the proposed estimator outperforms existing methods. Application of the proposed method is illustrated through analysis of the SUPPORT study.